[Combined therapy with recombinant alfa-2 and gamma interferons in patients with chronic hepatitis delta virus infection].
5 patients with chronic HD-viral infection received combined therapy with alpha 2 and gamma-interferons in daily doses 4000000 U for 30 days. In 1 patient with low-replicative form of hepatitis an AlAT activity decline and disappearance of serum IgM anti-D observed in the course of the treatment returned to pretreatment values one month after the end of therapy. In the other patient with high-replicative form of hepatitis a long suppression of viral replication was achieved, AlAT activity returned to normal. Low titers of IgM anti-D persisted for 5 months after therapy. The treatment failed in delta cirrhosis as activity of AlAT and IgM anti-D titers remained unchanged.